Trial Profile
Hemodynamic effects of Levosimendan in patient undergoing off–pump coronary artery bypass grafting and mitral valve replacement
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Oct 2022
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Dobutamine
- Indications Heart failure
- Focus Therapeutic Use
- 21 May 2018 New trial record